A Multiple Baseline Design Study to Investigate the Effectiveness of OT-SI Using an Intensive Intervention Model

March 29, 2019 updated by: Virginia Commonwealth University
The investigators hypothesize that children completing 30 sessions of occupational therapy using a sensory integration approach (OT-SI) will demonstrate positive changes in outcome measures related to motor coordination, functional performance and sensory processing (changes pre-post test).

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

3

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Virginia
      • Richmond, Virginia, United States, 23220
        • Children's Hospital of Richmond at VCU

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 8 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Have a medical diagnosis of "lack of coordination" or "other coordination impairment"
  • Children and caregivers able to communicate verbally in English
  • Sensory processing impairments as determined by scores in the SPM-H form (screening). Scores must fall in the "definite dysfunction" range in one of three categories (Body Awareness, Balance & Motion, or Planning & Ideas), OR fall in the "some problems" range in 2/3 areas.

Exclusion Criteria:

  • Diagnosed with autism spectrum disorder or other significant psychological impairment (e.g. bipolar disorder)
  • Receiving occupational therapy services at CHoR or another therapy site for more than 3 months
  • Significant motor impairment (e.g., cerebral palsy)
  • Significant language impairment (e.g., non-verbal, or aphasia)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: OT-SI
Occupational therapy using a sensory integration approach
Occupational therapy using a sensory integration approach (OT-SI) 3x per week for 10 weeks. A typical session will be 1 hour (total of 3 hours per week).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in motor coordination: Jumping Jacks
Time Frame: Baseline to 10 weeks
Amount of correct jumps in specified time frame (10 seconds)
Baseline to 10 weeks
Change in motor coordination: Finger to Nose Touching
Time Frame: Baseline to 10 weeks
Amount of correct touches in specified time frame (10 seconds)
Baseline to 10 weeks
Change in motor coordination: Single Leg Stance Balance
Time Frame: Baseline to 10 weeks
Time held in seconds
Baseline to 10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Sensory Processing Measure-Home Form
Time Frame: Baseline to 10 weeks
A standardized set of questionnaires used for rating a child's sensory processing issues, motor planning (praxis), and social participation.
Baseline to 10 weeks
Change in Bruinincks-Oseretsky Test of Motor Proficiency (BOT-2) Short-Form
Time Frame: Baseline to 10 weeks
A standardized assessment that uses goal-directed motor activities to measure a wide array of gross and fine motor skills in individuals 4-21 years old.
Baseline to 10 weeks
Change in Goal Attainment Scaling
Time Frame: Baseline to 10 weeks
Goal Attainment Scaling (GAS) is a way to develop individual goals for a patient that can be measured over the course of intervention using a standardized scale. Goals are rated on a 5-point scale and criteria for each level is established prior to starting treatment. While each patient has individual goals that are meaningful to him/her and his/her family, the outcome measurement scale is standardized so that it can be used for statistical analysis with other patients' goals. The expected level of outcome is established at initial goal setting, and 0 is used to rate an outcome where a patient achieves the expected level. If patient achieves a better than expected outcome, the score can be +1 (somewhat better) or +2 (much better). If patient achieves a worse outcome than expected, the score can be -1 (somewhat worse) or -2 (much worse). GAS goals are identified during semi-structured interview with patient and/or caregivers, and 3-4 goals are set and weighted by importance.
Baseline to 10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 12, 2018

Primary Completion (Actual)

March 20, 2019

Study Completion (Actual)

March 20, 2019

Study Registration Dates

First Submitted

November 20, 2017

First Submitted That Met QC Criteria

November 20, 2017

First Posted (Actual)

November 28, 2017

Study Record Updates

Last Update Posted (Actual)

April 1, 2019

Last Update Submitted That Met QC Criteria

March 29, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • HM20012008

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Motor Coordination or Function; Developmental Disorder

Clinical Trials on OT-SI

3
Subscribe